Dr Anthony Holmes
Anthony is a healthcare technology advisor and former CEO of Optasia Medical. After completing his PhD in 2001 with the University of Manchester Imaging Science group in breast cancer detection in mammograms, he joined Image Metrics to help commercialise machine learning algorithms in the healthcare, media and security domains. From 2006 until 2018 he worked at Optasia Medical, applying machine learning to musculoskeletal disease areas and obtaining regulatory clearance in Europe and the USA for medical device software. As CEO from 2013, he invented and managed the development of ASPIRE, a machine-learning powered and CQC-regulated teleradiology service for the diagnosis and referral of osteoporotic vertebral fracture patients, now deployed in several NHS Trusts. Anthony now works with a number of companies and universities, advising them on all aspects of commercialisation of machine learning.
Bridging the gap: how good ideas become great products
Artificial Intelligence is everywhere, or appears to be. Yet whilst it has the potential to make a big difference in healthcare, in truth there are still relatively few genuine AI deployments that genuinely impact patient outcomes. Based on two decades of experience commercialising AI in healthcare, Anthony will provide some ‘do’s and don’ts’ to consider when bringing AI algorithms
to market, including the most important: “Get out of the building!”.
EVEN MORE SEMINARS
Dr med. Christoph Juli FRCR, Consultant Cardiac Radiologist Medizinisches Diagnose-Zentrum Uster
Compressed SENSE Cardiac magnetic resonance (CMR) Imaging with the 1.5T Ambition X BlueSeal Magnet
Matthew Gardner RRPPS, University Hospitals Birmingham NHS Foundation Trust
Patient dosimetry audit for nuclear medicine and radiotherapy planning CT
Professor Dorothee Auer University of Nottingham
Novel MRI biomarkers in Parkinson’s
Sarah-May Gould King’s College London & Guy’s and St Thomas’ PET Centre
A Review of Attenuation Correction in Positron Emission Tomography
Dr Simeon Nill The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
MR image-guided radiotherapy treatment on the MR-Linac